Zobrazeno 1 - 10
of 68
pro vyhledávání: '"qw_805"'
Autor:
Stuart, ASV, Shaw, RH, Liu, X, Greenland, M, Aley, PK, Andrews, NJ, Cameron, JC, Charlton, S, Clutterbuck, EA, Collins, AM, Darton, T, Dinesh, T, Duncan, CJA, England, A, Faust, SN, Ferreira, DM, Finn, A, Goodman, AL, Green, CA, Hallis, B, Heath, PT, Hill, H, Horsington, BM, Lambe, T, Lazarus, R, Libri, V, Lillie, PJ, Mujadidi, YF, Payne, R, Plested, EL, Provstgaard-Morys, S, Ramasamy, MN, Ramsay, M, Read, RC, Robinson, H, Screaton, GR, Singh, N, Turner, DPJ, Turner, PJ, Vichos, I, White, R, Nguyen-Van-Tam, JS, Snape, MD, Com-COV2 Study Group
Publikováno v:
Lancet (London, England)
Snape, M D 2022, ' Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial ', Lancet, vol. 399, no. 10319, pp. 36-49 . https://doi.org/10.1016/S0140-6736(21)02718-5
Snape, M D 2022, ' Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2) : a single-blind, randomised, phase 2, non-inferiority trial ', Lancet, vol. 399, no. 10319, pp. 36-49 . https://doi.org/10.1016/S0140-6736(21)02718-5
Background Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied mixed priming schedules incorporating an adenoviral-vectored vaccine (ChAdOx1 nCoV-19 [ChAd], AstraZene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e72507942631237263460b52b50669b5
https://doi.org/10.1016/s0140-6736(21)02718-5
https://doi.org/10.1016/s0140-6736(21)02718-5
Autor:
Robert H Shaw, Xinxue Liu, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, J Claire Cameron, Sue Charlton, Elizabeth A Clutterbuck, Andrea M Collins, Wanwisa Dejnirattisai, Tanya Dinesh, Saul N Faust, Daniela M Ferreira, Adam Finn, Christopher A Green, Bassam Hallis, Paul T Heath, Helen Hill, Teresa Lambe, Rajeka Lazarus, Vincenzo Libri, Fei Long, Yama F Mujadidi, Emma L Plested, Ella R Morey, Samuel Provstgaard-Morys, Maheshi N Ramasamy, Mary Ramsay, Robert C Read, Hannah Robinson, Gavin R Screaton, Nisha Singh, David P J Turner, Paul J Turner, Iason Vichos, Laura L Walker, Rachel White, Jonathan S Nguyen-Van-Tam, Matthew D Snape, Alasdair P.S. Munro, Jazz Bartholomew, Laura Presland, Sarah Horswill, Sarah Warren, Sophie Varkonyi-Clifford, Stephen Saich, Kirsty Adams, Marivic Ricamara, Nicola Turner, Nicole Y. Yee Ting, Sarah Whittley, Tommy Rampling, Amisha Desai, Claire H. Brown, Ehsaan Qureshi, Karishma Gokani, Kush Naker, Johanna K. Kellett Wright, Rachel L. Williams, Tawassal Riaz, Florentina D. Penciu, Amy Carson, Claudio Di Maso, Gracie Mead, Elizabeth G. Howe, Mujtaba Ghulam Farooq, Rabiullah Noristani, Xin L. Yao, Neil J. Oldfield, Daniel Hammersley, Sue Belton, Simon Royal, Alberto San Francisco Ramos, Cecilia Hultin, Eva P. Galiza, Rebecca Crook, Marcin Bula, Fred Fyles, Hassan Burhan, Flora Maelin, Elen Hughes, Emmanuel Okenyi
Publikováno v:
Shaw, R H, Liu, X, Stuart, A S V, Greenland, M, Aley, P K, Andrews, N J, Finn, A & Lazarus, R & et, A 2022, ' Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules : exploratory analyses of Com-COV, a randomised control trial ', Lancet Respiratory Medicine, vol. 10, no. 11, pp. 1049-1060 . https://doi.org/10.1016/S2213-2600(22)00163-1
Background Priming COVID-19 vaccine schedules have been deployed at variable intervals globally, which might influence immune persistence and the relative importance of third-dose booster programmes. Here, we report exploratory analyses from the Com-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ed4ea510bf1be44fbc2afbfb9cf0590
https://eprints.soton.ac.uk/456454/
https://eprints.soton.ac.uk/456454/
Autor:
Todd D Swarthout, Marc Y R Henrion, Deus Thindwa, James E Meiring, Maurice Mbewe, Akuzike Kalizang’Oma, Comfort Brown, Jacquline Msefula, Brewster Moyo, Andrew A Mataya, Susanne Barnaba, Emma Pearce, Melita Gordon, David Goldblatt, Neil French, Robert S Heyderman
BACKGROUND: Pneumococcal conjugate vaccines (PCVs) induce serotype-specific IgG antibodies, effectively reducing vaccine-serotype carriage and invasive pneumococcal disease (IPD). IgG production wanes approximately 1 month after vaccination in absenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc54bb8b83f6bd3bcbd4c7909567cdba
https://archive.lstmed.ac.uk/21122/1/Lancet_Inf_Dis_1-s2.0-S1473309922004388-main.pdf
https://archive.lstmed.ac.uk/21122/1/Lancet_Inf_Dis_1-s2.0-S1473309922004388-main.pdf
Autor:
Pardeep Jagpal, Ruben Thanacoody, Laurence Gray, Thomas Lamb, Michael Eddleston, Dacia Jones, David Stewart, David G. Lalloo, David A. Warrell
Publikováno v:
Clinical Toxicology. 59:992-1001
Background\ud Bites by the European adder (Vipera berus) in the UK are uncommon but potentially life threatening, and can be associated with marked limb swelling and disability. Following an interruption in Zagreb Imunološki zavod antivenom supply a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::576acf465e01608b916c341da158be01
https://doi.org/10.1080/15563650.2021.1891245
https://doi.org/10.1080/15563650.2021.1891245
Autor:
Praet, Nicolas, Asante, Kwaku Poku, Bozonnat, Marie‑Cecile, Akité, Elaine Jacqueline, Ansah, Patrick Odum, Baril, Laurence, Boahen, Owusu, Mendoza, Yolanda Guerra, Haine, Valerie, Kariuki, Simon, Lamy, Mathieu, Maleta, Kenneth, Mungwira, Randy, Ndeketa, Latif, Oduro, Abraham, Ogutu, Bernhards, Olewe, Fredrick, Oneko, Martina, Orsini, Mattéa, Roman, Francois, Bahmanyar, Edith Roset, Rosillon, Dominique, Schuerman, Lode, Sing’oei, Valentine, Terlouw, Anja, Wéry, Stéphanie, Otieno, Walter, Pirçon, Jean‑Yves
Publikováno v:
Malaria Journal. 21
Background Following a 30-year development process, RTS,S/AS01E (GSK, Belgium) is the first malaria vaccine to reach Phase IV assessments. The World Health Organization-commissioned Malaria Vaccine Implementation Programme (MVIP) is coordinating the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979d919619c7830b74d76daa7a84e983
https://doi.org/10.1186/s12936-022-04144-3
https://doi.org/10.1186/s12936-022-04144-3
Autor:
Afran, Louise, Jambo, Kondwani, Nedi, Wilfred, Miles, David J C, Kiran, Anmol, Banda, Dominic H, Kamg’ona, Ralph, Tembo, Dumizulu, Pachnio, Annette, Nastouli, Eleni, Ferne, Brigit, Mwandumba, Henry, Moss, Paul, Goldblatt, David, Rowland-Jones, Sarah, Finn, Adam, Heyderman, Robert S
Background \ud HIV-Exposed Uninfected (HEU) infants are a rapidly expanding population in sub-Saharan Africa, highly susceptible to encapsulated bacterial disease in the first year of life. The mechanism of this increased risk is still poorly underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::7c848bb9c0b446165f7ba4b87874cd76
https://archive.lstmed.ac.uk/20293/1/jiac133.pdf
https://archive.lstmed.ac.uk/20293/1/jiac133.pdf
Autor:
Marah G. Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, Jonathan Mandolo, Tandile Hermanaus, Thopisang Motlou, Nonkululeko Mzindle, Frances Ayres, Mphatso Chaponda, Godwin Tembo, Percy Mwenechanya, Ndaona Mitole, Chisomo Jassi, Raphael Kamng’ona, Louise Afran, David Mzinza, Henry C. Mwandumba, Stephen B. Gordon, Khuzwayo Jere, Shabir Madhi, Penny L. Moore, Robert S. Heyderman, Kondwani C. Jambo
BackgroundBinding and neutralising anti-Spike antibodies play a key role in immune defence against SARS-CoV-2 infection. Since it is known that antibodies wane with time and new immune-evasive variants are emerging, we aimed to assess the dynamics of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54b13f09926c0573e166735672b1d690
https://archive.lstmed.ac.uk/20198/1/12916_2022_Article_2342.pdf
https://archive.lstmed.ac.uk/20198/1/12916_2022_Article_2342.pdf
Autor:
Prisca Benedicto-Matambo, Julie E. Bines, Chikondi Malamba-Banda, Isaac T. Shawa, Kayla Barnes, Arox W. Kamng’ona, Daniel Hungerford, Kondwani C. Jambo, Miren Iturriza-Gomara, Nigel A. Cunliffe, Katie L. Flanagan, Khuzwayo C. Jere
Following the introduction of live-attenuated rotavirus vaccines in many countries, a notable reduction in deaths and hospitalizations associated with diarrhoea in children
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3b3407a352db2799fac7e1ac05f452c
https://archive.lstmed.ac.uk/20092/1/vaccines-10-00418.pdf
https://archive.lstmed.ac.uk/20092/1/vaccines-10-00418.pdf
Autor:
Sophie I. Owen, Christopher T. Williams, Gala Garrod, Alice J. Fraser, Stefanie Menzies, Lisa Baldwin, Lottie Brown, Rachel L. Byrne, Andrea M. Collins, Ana I. Cubas-Atienzar, Margaretha de Vos, Thomas Edwards, Camille Escadafal, Daniela M. Ferreira, Tom Fletcher, Angela Hyder-Wright, Grant A. Kay, Konstantina Kontogianni, Jenifer Mason, Elena Mitsi, Tim Planche, Jilian A. Sacks, Joseph Taylor, Stacy Todd, Caroline Tully, Luis E. Cuevas, Emily R. Adams
Publikováno v:
The Journal of Infection
Background: \ud There are an abundance of commercially available lateral flow assays (LFAs) that detect antibodies to SARS-CoV-2. Whilst these are usually evaluated by the manufacturer, externally performed diagnostic accuracy studies to assess perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b71fc3efe1366a2ed6aaf669393e225b
https://openaccess.sgul.ac.uk/id/eprint/113964/7/1-s2.0-S0163445321005983-main.pdf
https://openaccess.sgul.ac.uk/id/eprint/113964/7/1-s2.0-S0163445321005983-main.pdf
Amid a surge of infections from the omicron coronavirus variant, revelations about high profile breaches of pandemic restrictions, and deepening tensions between Ukraine and Russia, a puzzling announcement has escaped the attention of many commentato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::cf0e44242ad925e5e351f62ccaeb7798